推进宫癌治疗:整合大麻素,组合疗法和纳米技术
S P Mathibela1, K N Ncube2, M T Lebelo1
1Department of Physiology, University of Pretoria, Private Bag X323, Gezina, Pretoria, 0031, South Africa.
大麻素显示承诺作为补充宫癌治疗通过抑制癌细胞的生长和扩散. 需要进一步的研究和临床试验来优化它们的使用并确保安全.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 纳米技术 纳米技术
背景情况:
- 子宫癌对全球健康造成重大负担,特别是在撒哈拉以南非洲.
- 尽管治疗进展,但高级和复发性宫癌的管理仍然具有挑战性.
研究的目的:
- 审查大麻素在宫癌治疗中的潜力.
- 探索与当前治疗,组合疗法和纳米技术交付的整合.
主要方法:
- 关于大麻素抗癌性质的临床前研究的批判综合.
- 检查作用机制和治疗应用.
- 综合和基于纳米技术的治疗方式的审查.
主要成果:
- 像THC和CBD这样的大麻素具有抗癌作用,诱导亡并抑制扩散/转移.
- 机制包括氧化应激,调节的信号通路和免疫反应.
- 组合疗法和纳米技术的交付提高了疗效,降低了毒性.
结论:
- 大麻素显示出作为宫癌辅助治疗的潜力.
- 临床翻译需要优化配方,剂量和安全性评估.
- 个性化医疗,标准化和监管考虑对整合至关重要.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
